164 related articles for article (PubMed ID: 22803663)
1. Structure-based design and biochemical evaluation of sulfanilamide derivatives as hepatitis B virus capsid assembly inhibitors.
Cho MH; Song JS; Kim HJ; Park SG; Jung G
J Enzyme Inhib Med Chem; 2013 Oct; 28(5):916-25. PubMed ID: 22803663
[TBL] [Abstract][Full Text] [Related]
2. Discovery and Mechanistic Study of Benzamide Derivatives That Modulate Hepatitis B Virus Capsid Assembly.
Wu S; Zhao Q; Zhang P; Kulp J; Hu L; Hwang N; Zhang J; Block TM; Xu X; Du Y; Chang J; Guo JT
J Virol; 2017 Aug; 91(16):. PubMed ID: 28566379
[TBL] [Abstract][Full Text] [Related]
3. An in vitro fluorescence screen to identify antivirals that disrupt hepatitis B virus capsid assembly.
Stray SJ; Johnson JM; Kopek BG; Zlotnick A
Nat Biotechnol; 2006 Mar; 24(3):358-62. PubMed ID: 16474383
[TBL] [Abstract][Full Text] [Related]
4. 2-amino-N-(2,6-dichloropyridin-3-yl)acetamide derivatives as a novel class of HBV capsid assembly inhibitor.
Cho MH; Jeong H; Kim YS; Kim JW; Jung G
J Viral Hepat; 2014 Dec; 21(12):843-52. PubMed ID: 24372792
[TBL] [Abstract][Full Text] [Related]
5. Modulators of HBV capsid assembly as an approach to treating hepatitis B virus infection.
Cole AG
Curr Opin Pharmacol; 2016 Oct; 30():131-137. PubMed ID: 27636324
[TBL] [Abstract][Full Text] [Related]
6. Global structural changes in hepatitis B virus capsids induced by the assembly effector HAP1.
Bourne CR; Finn MG; Zlotnick A
J Virol; 2006 Nov; 80(22):11055-61. PubMed ID: 16943288
[TBL] [Abstract][Full Text] [Related]
7. Novel non-HAP class A HBV capsid assembly modulators have distinct
Vanrusselt H; Kum DB; Taverniti V; Liu C; Acosta Sanchez A; Corthout N; Munck S; Baumert TF; Beigelman L; Blatt LM; Symons JA; Deval J; Raboisson P; Verrier ER; Jekle A; Vendeville S; Debing Y
J Virol; 2023 Oct; 97(10):e0072223. PubMed ID: 37754761
[TBL] [Abstract][Full Text] [Related]
8. Calcium ions affect the hepatitis B virus core assembly.
Choi Y; Gyoo Park S; Yoo JH; Jung G
Virology; 2005 Feb; 332(1):454-63. PubMed ID: 15661175
[TBL] [Abstract][Full Text] [Related]
9. BAY 41-4109 has multiple effects on Hepatitis B virus capsid assembly.
Stray SJ; Zlotnick A
J Mol Recognit; 2006; 19(6):542-8. PubMed ID: 17006877
[TBL] [Abstract][Full Text] [Related]
10. A heteroaryldihydropyrimidine activates and can misdirect hepatitis B virus capsid assembly.
Stray SJ; Bourne CR; Punna S; Lewis WG; Finn MG; Zlotnick A
Proc Natl Acad Sci U S A; 2005 Jun; 102(23):8138-43. PubMed ID: 15928089
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B Virus Capsids Have Diverse Structural Responses to Small-Molecule Ligands Bound to the Heteroaryldihydropyrimidine Pocket.
Venkatakrishnan B; Katen SP; Francis S; Chirapu S; Finn MG; Zlotnick A
J Virol; 2016 Apr; 90(8):3994-4004. PubMed ID: 26842475
[TBL] [Abstract][Full Text] [Related]
12. An Aptamer against the Matrix Binding Domain on the Hepatitis B Virus Capsid Impairs Virion Formation.
Orabi A; Bieringer M; Geerlof A; Bruss V
J Virol; 2015 Sep; 89(18):9281-7. PubMed ID: 26136564
[TBL] [Abstract][Full Text] [Related]
13. Assembly Properties of Hepatitis B Virus Core Protein Mutants Correlate with Their Resistance to Assembly-Directed Antivirals.
Ruan L; Hadden JA; Zlotnick A
J Virol; 2018 Oct; 92(20):. PubMed ID: 30089690
[TBL] [Abstract][Full Text] [Related]
14. A new series of HAPs as anti-HBV agents targeting at capsid assembly.
Yang XY; Xu XQ; Guan H; Wang LL; Wu Q; Zhao GM; Li S
Bioorg Med Chem Lett; 2014 Sep; 24(17):4247-9. PubMed ID: 25127104
[TBL] [Abstract][Full Text] [Related]
15. Heteroaryldihydropyrimidines Alter Capsid Assembly By Adjusting the Binding Affinity and Pattern of the Hepatitis B Virus Core Protein.
Liu H; Okazaki S; Shinoda W
J Chem Inf Model; 2019 Dec; 59(12):5104-5110. PubMed ID: 31756297
[TBL] [Abstract][Full Text] [Related]
16. Interaction between nucleophosmin and HBV core protein increases HBV capsid assembly.
Jeong H; Cho MH; Park SG; Jung G
FEBS Lett; 2014 Mar; 588(6):851-8. PubMed ID: 24462683
[TBL] [Abstract][Full Text] [Related]
17. Review of small synthetic molecules targeting HBV capsid assembly.
Liu N; Zhao F; Zhan P; Liu X
Med Chem; 2015; 11(8):710-6. PubMed ID: 25985859
[TBL] [Abstract][Full Text] [Related]
18. Discovery of New Small Molecule Hits as Hepatitis B Virus Capsid Assembly Modulators: Structure and Pharmacophore-Based Approaches.
Senaweera S; Du H; Zhang H; Kirby KA; Tedbury PR; Xie J; Sarafianos SG; Wang Z
Viruses; 2021 Apr; 13(5):. PubMed ID: 33925540
[TBL] [Abstract][Full Text] [Related]
19. Pyrimidotriazine derivatives as selective inhibitors of HBV capsid assembly.
Toyama M; Sakakibara N; Takeda M; Okamoto M; Watashi K; Wakita T; Sugiyama M; Mizokami M; Ikeda M; Baba M
Virus Res; 2019 Oct; 271():197677. PubMed ID: 31376401
[TBL] [Abstract][Full Text] [Related]
20. Molecular Dynamics Simulations to Determine the Structure and Dynamics of Hepatitis B Virus Capsid Bound to a Novel Anti-viral Drug.
Watanabe G; Sato S; Iwadate M; Umeyama H; Hayakawa M; Murakami Y; Yoneda S
Chem Pharm Bull (Tokyo); 2016; 64(9):1393-6. PubMed ID: 27581644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
